PLTR is trading at 4.02% down now at $178.00 after a sharp reversal despite recent positive news that OneMedNet Corporation selected Palantir Technologies to provide AI infrastructure for its advanced healthcare data and analytics initiative. While this partnership underscores Palantir’s growing presence in healthcare analytics, analysts note that the near-term revenue impact is likely modest compared to larger government or commercial contracts, and concerns about Palantir’s high valuation and operational risks remain prominent. The broader market is also under pressure, with the S&P 500 down 2.1% and the NASDAQ down 2.67% as of 3:00 PM EST, contributing to the negative sentiment and amplifying PLTR’s decline.